The changing landscape of gene therapy and standardized endpoints
Season 2, Episode 3, Feb 23, 2022, 04:10 PM
Keith Lane of Orange Clinical joins us to discuss the current state of gene therapy and its standardized endpoints, and the challenges gene therapy has faced, particularly in relation to ophthalmology.